Thomas J. Herzog, MD
Director
Columbia University College of Physicians and Surgeons
Herbert Irving Pavilion
161 Fort Washington Ave
New York,
NY
USA
10032
Papers:
13 - Focused Plenary
Comparative effectiveness of radical hysterectomy in elderly women with cervical cancer
101 -Featured Poster
Evaluation of CA-125 response in the TRINOVA-1 study of weekly paclitaxel plus trebananib or placebo in women with recurrent ovarian cancer
138 - Scientific Plenary
Health-related quality-of-life analysis from the TRINOVA-1 study of weekly paclitaxel plus trebananib or placebo in women with recurrent ovarian cancer
205 - Poster Session A
Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer
449 - Poster Session B
Adverse event profile by folate receptor status for vintafolide+pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer
450 - Poster Session B
Model prediction of mean PFS and OS time from a phase II trial comparing vintafolide plus pegylated liposomal doxorubicin versus pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer patients with 100% folate receptor–positive target
517 - Poster Session B
Surveillance Testing in Women Following a Diagnosis of Early-Stage Endometrial Cancer
Late Breaking Abstract 3
Geriatric assessment and tolerance to chemotherapy in elderly women with ovarian, primary peritoneal or fallopian tube cancer: a Gynecologic Oncology Group study